41-60 of 7,469 results for subject:"Hazardous substances"
Librarians' tools
- Search time
- 0.484 seconds
- Solr query time
- 0.018 seconds
- Search query
- subject:"Hazardous substances"
- We searched for
- subject_t:"Hazardous substances" OR subject_t:"Dangerous goods" OR subject_t:"Hazardous materials" OR subject_ses:91479
Type
House
Session
More
Year
More
Department
More
Member
More
Primary member
More
Answering member
More
Legislative stage
Legislation
More
Subject
More
Publisher
To ask the Secretary of State for Work and Pensions, what steps his Department is taking to promote the use of (a) biological safety cabinets, (b) closed‑system drug‑transfer devices and (c) other engineering controls during (i) preparation and (ii) administration of hazardous medicinal products; and whether he plans to provide...
To ask the Secretary of State for Work and Pensions, what steps his Department is taking to promote the use of (a) biological safety cabinets, (b) closed‑system drug‑transfer devices and (c) other engineering controls during (i) preparation and (ii) administration of hazardous medicinal products; and whether he plans to provide...
I refer the Honourable Member to the previous answer 84144.
To ask the Secretary of State for Work and Pensions, if his Department will review the adequacy of the Control of Substances Hazardous to Health Regulations to ensure that hazardous medicinal products with reprotoxic effects are controlled to the same standard as (a) carcinogens and (b) mutagens.
To ask the Secretary of State for Work and Pensions, if his Department will review the adequacy of the Control of Substances Hazardous to Health Regulations to ensure that hazardous medicinal products with reprotoxic effects are controlled to the same standard as (a) carcinogens and (b) mutagens.
I refer the Honourable Member to the previous answer 84440.
To ask the Secretary of State for Environment, Food and Rural Affairs, what recent discussions she has had with the Environment Agency on the regulation of hazardous waste storage at industrial sites in Teesside.
To ask the Secretary of State for Environment, Food and Rural Affairs, what recent discussions she has had with the Environment Agency on the regulation of hazardous waste storage at industrial sites in Teesside.
Industrial sites must only store hazardous waste in accordance with an environmental permit.
To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of (a) nurses and (b) other healthcare professionals exposed to hazardous medicinal products.
To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of (a) nurses and (b) other healthcare professionals exposed to hazardous medicinal products.
The Department has not made an estimate of the number of (a) nurses and (b) other healthcare professionals exposed to hazardous medicinal products.
Any incidents involving staff exposure to hazardous medical products are reported and handled through local National Health Service body reporting procedures. Risk assessments should be undertaken routinely and mitigations put in place to minimise any environmental exposure to health care professionals (and others) relating to “hazardous medicinal products”.
To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of (a) nurses and (b) other healthcare professionals exposed to hazardous medicinal products.
To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of (a) nurses and (b) other healthcare professionals exposed to hazardous medicinal products.
The Department has not made an estimate of the number of (a) nurses and (b) other healthcare professionals exposed to hazardous medicinal products.
Any incidents involving staff exposure to hazardous medical products are reported and handled through local National Health Service body reporting procedures. Risk assessments should be undertaken routinely and mitigations put in place to minimise any environmental exposure to health care professionals (and others) relating to “hazardous medicinal products”.
To ask the Secretary of State for Work and Pensions, which chemical substances have received EU Harmonised Classification and GB Mandatory Classification since 1 January 2021 by (a) chemical name, (b) European Community number, (c) CAS Registry Number, (d) EU harmonised classification (i) hazard class and category code and (ii)...
To ask the Secretary of State for Work and Pensions, which chemical substances have received EU Harmonised Classification and GB Mandatory Classification since 1 January 2021 by (a) chemical name, (b) European Community number, (c) CAS Registry Number, (d) EU harmonised classification (i) hazard class and category code and (ii)...
Since 1 January 2021, the Health and Safety Executive (HSE), as the regulator, has acted as the Agency for the assimilated Regulation (EC) No. 1272/2008 on classification, labelling and packaging of substances and mixtures as amended in Great Britain (or the GB CLP Regulation).
HSE is responsible for the GB mandatory classification and labelling system (GB MCL) and for updating the GB MCL List on the HSE website with new/revised or deleted entries in accordance with a timetable set out in UK law. The GB MCL List entries provide information on chemical substances that have GB MCLs including: a) chemical name, (b) European Community number, (c) CAS Registry Number, (e) GB Mandatory Classification and Labelling (i) Hazard class and category code, (ii) Hazard statement code and (iii) date of entry into legal effect.
The GB MCL List does not include information on the EU harmonised classification and labelling, hazard class and category code and hazard statement code for these chemical substances. This information is available on the European Chemicals Agency website in the unofficial ‘Table of harmonised entries containing all updates to the harmonised classification and labelling of hazardous substances, available in Table 3 of Annex VI to the EU CLP Regulation’.
The GB MCL List includes 4430 entries. Since 1 January 2021, 206 chemical substances have received GB MCLs, following a recommendation by HSE as the Agency and a Ministerial Decision made with the consent of Scottish and Welsh Ministers. The GB MCL entries for the 206 entries, including the requested information, are published in the GB MCL List on the HSE website – please see https://www.hse.gov.uk/chemical-classification/classification/mcl-list.htm.
To ask the Secretary of State for Work and Pensions, what steps he is taking to promote the use of (a) biological safety cabinets, (b) closed-system drug-transfer devices and (c) other engineering controls during (i) preparation and (ii) administration of hazardous medicinal products; and whether he plans to provide funding...
To ask the Secretary of State for Work and Pensions, what steps he is taking to promote the use of (a) biological safety cabinets, (b) closed-system drug-transfer devices and (c) other engineering controls during (i) preparation and (ii) administration of hazardous medicinal products; and whether he plans to provide funding...
Where hazardous medicinal products (HMPs) are substances hazardous to health subject to The Control of Substances Hazardous to Health Regulations 2002 (as amended) (COSHH) employers, including NHS Trusts, are required to comply with the requirements of these regulations.
The regulations require employers who prepare and administer substances hazardous to health to undertake a risk assessment, the purpose of which is to make valid decisions about the measures needed to prevent, or where this is not reasonably practicable, adequately control the exposure of their employees to substances hazardous to health.
If it is not reasonably practicable for an employer to prevent exposure, the regulations require that the exposure of employees is adequately controlled and through the risk assessment process that the employer considers and identifies the control measures that should be implemented. Priority should be given to those controls that contain or minimise the release of contaminants and the spread of hazardous substances into the workplace.
The Approved Code of Practice and guidance to the COSHH regulations provides employers with detailed information and guidance on the requirements of the regulations. The Health and Safety Executive (HSE) has also produced specific guidance on it’s website on the Safe handling of cytotoxic drugs in the workplace, which are one particular type of HMP.
To ask the Secretary of State for Work and Pensions, whether he will require NHS employers to provide ongoing (a) education, (b) training and (c) health surveillance for all staff who (i) handle and (ii) may be exposed to hazardous medicinal products.
To ask the Secretary of State for Work and Pensions, whether he will require NHS employers to provide ongoing (a) education, (b) training and (c) health surveillance for all staff who (i) handle and (ii) may be exposed to hazardous medicinal products.
Where hazardous medicinal products (HMPs) are substances hazardous to health within the meaning of The Control of Substances Hazardous to Health Regulations 2002 (as amended) (COSHH), every employer is required to provide that employee with suitable and sufficient information, instruction and training.
COSHH sets out specific requirements for where health surveillance is appropriate for the protection of the health of employees who are, or are liable to be, exposed to a substance hazardous to health. This includes where the exposure of the employee to a substance hazardous to health is such that –
(i) an identifiable disease or adverse health effect may be related to the exposure;
(ii) there is a reasonable likelihood that the disease or effect may occur under the particular conditions of his work; and
(iii) (iii) there are valid techniques for detecting indications of the disease or effect and the technique of investigation is of low risk to the employee.
It is therefore for the employer to determine if health surveillance is appropriate as part of it’s duties under COSHH.
To ask the Secretary of State for Work and Pensions, if he will make it his policy to bring forward legislative proposals to amend the Control of Substances Hazardous to Health Regulations 2002 to ensure that hazardous medicinal products with reprotoxic effects are controlled to the same standard as carcinogens...
To ask the Secretary of State for Work and Pensions, if he will make it his policy to bring forward legislative proposals to amend the Control of Substances Hazardous to Health Regulations 2002 to ensure that hazardous medicinal products with reprotoxic effects are controlled to the same standard as carcinogens...
The Health and Safety Executive (HSE) has no current plans to amend The Control of Substances Hazardous to Health Regulations 2002 (COSHH) (as amended). These regulations place duties on all employers to assess the risk and ensure that the exposure of their employees to substances hazardous to health is either prevented or, where this is not reasonably practicable, adequately controlled. This includes any hazardous substances within hazardous medicinal products.
COSHH requires employers to carry out their risk assessments to establish the hazards arising from work activities, including the products and processes being used, and for the employer to put measures in place to control those risks. The risk assessment must take into account the properties of the hazardous substance and how and when they can give rise to risks to health.
If exposure cannot be prevented, employers must implement an effective programme of management procedures and put in place and maintain suitable and sufficient control measures to mitigate against the risks to health posed by any such exposure.
To ask the Secretary of State for Work and Pensions, whether his Department plans to (a) (i) develop and (ii) adopt a list of hazardous medicinal products and (b) require safety data sheets for finished medicines; and if he will take steps with the Health and Safety Executive to make...
To ask the Secretary of State for Work and Pensions, whether his Department plans to (a) (i) develop and (ii) adopt a list of hazardous medicinal products and (b) require safety data sheets for finished medicines; and if he will take steps with the Health and Safety Executive to make...
The Health and Safety Executive (HSE) has no current plans to develop or adopt a list of hazardous medicinal products. The GB Classification, Labelling and Packaging of Chemicals Regulations 2009 (GB CLP) is disapplied to medicinal products in their finished state as outlined in Article 1(5)(a) of GB CLP.
Furthermore, the Registration, Evaluation, Authorisation and Restriction of Chemicals Regulations 2006 include an exemption from the need to provide a safety data sheet (SDS) for substances and mixtures intended for medicinal products. This occurs to avoid duplication when other more specific legislation exists to regulate those uses. Medicinal products for human and veterinary use, which are within the scope of the Human Medicines Regulations 2012 or the Veterinary Medicines Regulations 2013, are partially exempt from REACH for this reason. The responsibility for the REACH legislation lies with the Secretary of State for the Department for Environment, Food and Rural Affairs (DEFRA).
Lords motion to approve. Amendment to regret debated and withdrawn. Original motion agreed to on question.
Lords motion to approve. Amendment to regret debated and withdrawn. Original motion agreed to on question.
My Lords, this instrument introduces the mechanisms to enforce the EU mercury regulation in Northern Ireland under the Windsor Framework, which maintains Northern Ireland’s dual market access to the EU single market and the
UK internal market. I know that questions of democratic legitimacy and the effectiveness of the Windsor...
My Lords, this instrument introduces the mechanisms to enforce the EU mercury regulation in Northern Ireland under the Windsor Framework, which maintains Northern Ireland’s dual market access to the EU single market and the
UK internal market. I know that questions of democratic legitimacy and the effectiveness of the Windsor...
Moved by
Baroness Hoey
Moved by
Baroness Hoey
My Lords, it is nice to see the noble Baroness answering on this statutory instrument, and I thank her for her outline of what it contains. I reassure noble Lords that, while the Whip’s notice says that today’s rising time will probably be about 7 pm, I have no intention—I...
My Lords, it is nice to see the noble Baroness answering on this statutory instrument, and I thank her for her outline of what it contains. I reassure noble Lords that, while the Whip’s notice says that today’s rising time will probably be about 7 pm, I have no intention—I...
My Lords, I will make a briefer speech, not on the constitutional aspect of this but on the dentistry aspect. I thank the Minister for introducing this, and indeed the noble Baroness for moving her amendment. I do recognise that there is a very important constitutional issue as well. The...
My Lords, I will make a briefer speech, not on the constitutional aspect of this but on the dentistry aspect. I thank the Minister for introducing this, and indeed the noble Baroness for moving her amendment. I do recognise that there is a very important constitutional issue as well. The...
My Lords, I am pleased to support the amendment from the noble Baroness, Lady Hoey. There is no doubt that one of our greatest national institutions is the NHS. The people of the United Kingdom have in the past been exercised about the possibility that those whom they elect might...
My Lords, I am pleased to support the amendment from the noble Baroness, Lady Hoey. There is no doubt that one of our greatest national institutions is the NHS. The people of the United Kingdom have in the past been exercised about the possibility that those whom they elect might...
My Lords, I thank the Minister for introducing this debate and the noble Baroness, Lady Hoey, for her amendment. This SI addresses the implications for Northern Ireland of the Government’s decision not to follow the Minamata Convention on Mercury on phasing out the use of mercury dental amalgam fillings throughout...
My Lords, I thank the Minister for introducing this debate and the noble Baroness, Lady Hoey, for her amendment. This SI addresses the implications for Northern Ireland of the Government’s decision not to follow the Minamata Convention on Mercury on phasing out the use of mercury dental amalgam fillings throughout...
My Lords, I thank the Minister for her statement, which filled out very carefully the exact situation that we now face with amalgam fillings in a useful and important way. I am very grateful for that.
The noble Baroness, Lady Hoey, is right on one key point. I have friends in...
My Lords, I thank the Minister for her statement, which filled out very carefully the exact situation that we now face with amalgam fillings in a useful and important way. I am very grateful for that.
The noble Baroness, Lady Hoey, is right on one key point. I have friends in...
My Lords, earlier today we had a haul of Earls—I think that was the collective term. In this debate on issues that pertain to the protocol and the Windsor Framework, I rise as one of a number of unionist Peers. I am not sure what the collective term is, whether...
My Lords, earlier today we had a haul of Earls—I think that was the collective term. In this debate on issues that pertain to the protocol and the Windsor Framework, I rise as one of a number of unionist Peers. I am not sure what the collective term is, whether...
My Lords, I thank the Minister for her very clear introduction to this statutory instrument and the noble Baroness,
Lady Hoey, for raising this issue, even though I will take a very different approach to the SI. I will park the constitutional questions, leaving the Windsor Framework to one side,...
My Lords, I thank the Minister for her very clear introduction to this statutory instrument and the noble Baroness,
Lady Hoey, for raising this issue, even though I will take a very different approach to the SI. I will park the constitutional questions, leaving the Windsor Framework to one side,...